Navigation Links
Global Companion Diagnostics Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2019
Date:8/5/2014

Albany,NY (PRWEB) August 05, 2014

Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide.

Title: Companion Diagnostics Market
Published: 29 Aug 2013
Pages: 89
Price: US$ 4,595.00 (Single User)
For further inquiries, click here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387.

Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers. Pharmaceutical companies are either focusing on in-house development of companion diagnostics or development in collaboration with diagnostics companies. This strategy focusing on the co-development of a drug and its companion diagnostic will prove to be advantageous over the conventional development process occurring in isolation.

The global companion diagnostics market can be categorized by tests for various indications and geography. Companion diagnostics market for breast cancer was the most prominent segment of the market in 2012 by revenue. Extensive research on breast cancer biomarkers and a paradigm shift towards personalized medicine will continue to propel the adoption of breast cancer companion diagnostics. However, another attractive segment of this market is that of lung cancer companion diagnostics, with the discovery of lung cancer specific biomarkers and an elaborate pipeline of related companion diagnostics for the same. It is estimated that the global market for lung cancer companion diagnostics will grow at a CAGR of over 20% from 2013 to 2019.

Browse the full Companion Diagnostics Market Report: http://www.transparencymarketresearch.com/companion-diagnostics-market.html.

At a regional level, North America was the largest market in 2012 for companion diagnostics, followed by the European region. The favorable healthcare policies, large consumer base, high disposable incomes, increased awareness, presence of suitable infrastructure facilities and ready acceptance of novel approaches in medicine will propel rapid development of companion diagnostics in the North American market. The Asia-Pacific and RoW regions are expected to experience commendable growth by 2019 due to the huge untapped potential, rising disposable incomes and continuous improvements in healthcare infrastructure.

The companion diagnostics market is characterized by the presence of established diagnostics manufacturers as well as small players solely operating in this market. The major companies competing in this market are Roche Holdings AG, Qiagen N.V., Abbott Laboratories, Agilent Technologies, Inc., Genomic Health, Inc., GE Healthcare Ltd., Life Technologies Corporation, and Agendia N.V.

The global companion diagnostics market is segmented as follows:

Companion Diagnostics Market, by Indications

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others (HIV, Thalassemia)

Companion Diagnostics Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Contact:
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA/Canada Toll Free: 866-552-3453
Email: sales(at)transparencymarketresearch(dot)com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12072489.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Intarcia Announces Appointment Of Dr. Sunita Zalani As Vice President, Global Head Of Regulatory Affairs And Quality
2. 2-EH Market & Linear Alkyl Benzene Industry – Global, China Regions Research Analysis Now Available at DeepResearchReports.com
3. Intrexon to Present at Jefferies 2014 Global Industrials Conference
4. Agem Global to Boost PPP and Listings
5. Global Biophotonics Market is Expected to Reach USD 50.20 Billion in 2020: Transparency Market Research
6. Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018
7. Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR
8. Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com
9. Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research
10. Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research
11. Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... coverage option for U.S. consumers who want to have ... DarioHealth has signed strategic alliance agreements with partners across ... coverage benefits, and if approved, will supply and bill ...
(Date:3/24/2017)... , March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" or ... China , today announced that its board of ... date of the plan from March 27, 2017 to March 27, ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the premiere team-building ... challenges for companies around the world, such as Illumina, HP and Qualcomm, and is ranked ... its increasing popularity is due to its new team building format, a way for teams ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
Breaking Biology Technology:
(Date:3/20/2017)... HANOVER, Germany , March 20, 2017 At ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the ... Japan is this year,s CeBIT partner country. At the largest ... important biometrics in use: fingerprint, face and iris recognition as well as ... ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):